Equities research analysts forecast that MedEquities Realty Trust Inc. (NYSE:MRT) will announce $14.72 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for MedEquities Realty Trust’s earnings, with the highest sales estimate coming in at $15.19 million and the lowest estimate coming in at $14.28 million. The business is expected to announce its next quarterly earnings results after the market closes on Tuesday, August 8th.

According to Zacks, analysts expect that MedEquities Realty Trust will report full year sales of $14.72 million for the current financial year, with estimates ranging from $61.04 million to $62.82 million. For the next financial year, analysts expect that the firm will report sales of $77.21 million per share, with estimates ranging from $76.12 million to $78.40 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for MedEquities Realty Trust.

Separately, Zacks Investment Research cut shares of MedEquities Realty Trust from a “hold” rating to a “sell” rating in a research note on Wednesday, May 3rd. Two research analysts have rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the stock. MedEquities Realty Trust presently has an average rating of “Hold” and an average target price of $12.86.

WARNING: “MedEquities Realty Trust Inc. (NYSE:MRT) Expected to Post Quarterly Sales of $14.72 Million” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://www.thecerbatgem.com/2017/08/07/medequities-realty-trust-inc-nysemrt-expected-to-post-quarterly-sales-of-14-72-million-updated-updated-updated.html.

MedEquities Realty Trust (NYSE MRT) traded up 0.98% on Friday, hitting $12.38. The stock had a trading volume of 34,860 shares. MedEquities Realty Trust has a 52-week low of $10.28 and a 52-week high of $13.06. The company has a market cap of $393.36 million and a P/E ratio of 476.15. The firm’s 50-day moving average is $12.09 and its 200-day moving average is $11.50.

Several large investors have recently modified their holdings of the company. GSA Capital Partners LLP acquired a new stake in shares of MedEquities Realty Trust during the fourth quarter valued at approximately $229,000. Metropolitan Life Insurance Co. NY bought a new position in MedEquities Realty Trust during the fourth quarter valued at $297,000. Teachers Advisors LLC bought a new position in MedEquities Realty Trust during the fourth quarter valued at $257,000. Norges Bank bought a new position in MedEquities Realty Trust during the fourth quarter valued at $3,108,000. Finally, Allianz Asset Management AG bought a new position in MedEquities Realty Trust during the fourth quarter valued at $125,000. Institutional investors own 95.72% of the company’s stock.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MedEquities Realty Trust (NYSE:MRT)

Receive News & Stock Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related stocks with our FREE daily email newsletter.